Effects of dutasteride on storage and voiding symptoms in male patients with lower urinary tract symptoms as a result of benign prostatic obstruction: The 1-year outcomes from a prospective urodynamic study

2014 ◽  
Vol 21 (8) ◽  
pp. 826-830 ◽  
Author(s):  
Yoshihisa Matsukawa ◽  
Momokazu Gotoh ◽  
Masashi Kato ◽  
Yasuhito Funahashi ◽  
Michiro Narita ◽  
...  
Keyword(s):  
Urinary Tract ◽  
Lower Urinary Tract Symptoms ◽  
Lower Urinary Tract ◽  
Urodynamic Study ◽  
Benign Prostatic Obstruction ◽  
Voiding Symptoms ◽  
Urinary Tract Symptoms ◽  
Male Patients ◽  
Lower Urinary

scholarly journals The Value of Urodynamic Study for Diagnosing the Causes of Lower Urinary Tract Symptoms in Male Patients: A Study From Iran

2016 ◽  
Vol 8 (4) ◽  
Author(s):  
Fatemeh Heydari ◽  
Bentolhoda Rezadoust ◽  
Shahin Abbaszade ◽  
Eidi Jahan Afrouz ◽  
Alireza Ghadian
Keyword(s):  
Urinary Tract ◽  
Lower Urinary Tract Symptoms ◽  
Lower Urinary Tract ◽  
Urodynamic Study ◽  
Urinary Tract Symptoms ◽  
Male Patients ◽  
Lower Urinary

scholarly journals Effect of Calcium Channel Blockers on Lower Urinary Tract Symptoms: A Systematic Review

2017 ◽  
Vol 2017 ◽  
pp. 1-7 ◽  
Author(s):  
Muhammad Salman ◽  
Amer Hayat Khan ◽  
Syed Azhar Syed Sulaiman ◽  
Junaid Habib Khan ◽  
Khalid Hussain ◽  
...  
Keyword(s):  
Urinary Tract ◽  
Calcium Channel ◽  
Lower Urinary Tract Symptoms ◽  
Calcium Channel Blockers ◽  
Lower Urinary Tract ◽  
Channel Blockers ◽  
Inverse Association ◽  
Voiding Symptoms ◽  
Urinary Tract Symptoms ◽  
Lower Urinary

Background. Numerous medications are known to be associated with the development of lower urinary tract symptoms (LUTS). One such medication group is calcium channel blockers (CCB). Objective. To critically examine the literature regarding the involvement of CCB in manifestation of LUTS in humans. Methods. A systematic literature search was conducted on PubMed, SciELO, Scopus, and OpenGrey databases to find all potentially relevant research studies before August 2016. Results. Five studies met the inclusion criteria and were included in this review. Three out of five studies stated that CCB were involved in either precipitation or exacerbation of LUTS. As for the remaining two studies, one study found out that only the monotherapy of CCB was associated with increased prevalence of nocturia and voiding symptoms in young females, whereas the other study reported an inverse association of CCB with LUTS. The methodological quality of studies was considered high for four studies and low for one study. Conclusion. Healthcare providers should make efforts for an earlier identification of the individuals at risk of LUTS prior to the commencement of CCB therapy. Moreover, patients should be counselled to notify their healthcare provider if they notice urinary symptoms after the initiation of CCB.

scholarly journals Population-Based Study of Prevalence, Bother and Behavior Related to Treatment for Lower Urinary Tract Symptoms and Overactive Bladder among Polish Neurogenic Patients

2021 ◽  
Vol 11 (6) ◽  
pp. 712
Author(s):  
Mikolaj Przydacz ◽  
Marcin Chlosta ◽  
Tomasz Golabek ◽  
Piotr Chlosta
Keyword(s):  
Urinary Tract ◽  
Overactive Bladder ◽  
Lower Urinary Tract Symptoms ◽  
Lower Urinary Tract ◽  
Population Level ◽  
Computer Assisted ◽  
Voiding Symptoms ◽  
Urinary Tract Symptoms ◽  
And Behavior ◽  
Lower Urinary

Background: The aim of this study was to perform a cross-sectional study of Polish neurogenic patients to measure, at the population level, the prevalence, bother and behavior associated with treatment for lower urinary tract symptoms (LUTS) and overactive bladder (OAB). Methods: This epidemiological study was based on data from LUTS POLAND, a computer-assisted and population-representative telephone survey. Participants were classified by age, sex and place of residence. Results: LUTS POLAND includes 6005 completed interviews, of which 1166 (19.4%) were for individuals who had ever received any treatment by neurologists and/or neurosurgeons. Among these neurogenic participants, LUTS prevalence was 72.3%, statistically higher than for non-neurogenic respondents. At the population level, neurogenic patients had about a 20% higher risk for LUTS presence than non-neurogenic participants (relative risk: 1.17–1.21). LUTS prevalence did not differ between men and women. Frequency was the most common of the LUTS. Forty percent of neurogenic respondents described having more than one LUTS subtype (i.e., storage, voiding, and/or post-micturition symptom subtype), and more than 50% of respondents reported OAB symptoms. Both storage and voiding symptoms were bothersome, and many neurogenic individuals (42.3–51.0%) expressed anxiety about bladder function affecting quality of life. Only one-third (34.9–36.6%) of neurogenic participants had sought treatment for their LUTS, and the majority of such individuals received and maintained treatment. Conclusions: LUTS and OAB symptoms were highly prevalent and bothersome among Polish neurogenic patients at the population level. Because the scale of seeking treatment for LUTS was low, Polish neurogenic patients may not be adequately informed about multiple effects of LUTS and OAB.

Sign in / Sign up

Export Citation Format

Share Document